Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
130.9 USD | -0.62% | +0.61% | +20.18% |
15/05 | Merck to present new oncology data | CF |
14/05 | US FDA declines to approve expanded use of Dynavax's hepatitis B vaccine | RE |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.18% | 33TCr | |
+32.85% | 71TCr | |
+30.77% | 60TCr | |
-1.75% | 37TCr | |
+5.99% | 29TCr | |
+14.77% | 24TCr | |
+9.13% | 21TCr | |
-3.97% | 20TCr | |
+9.39% | 17TCr | |
+0.55% | 16TCr |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Transcript : Merck & Co., Inc. - Shareholder/Analyst Call